Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0000950170-24-018893 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | LAB | Casdin Eli | Dir, 10% | A - Grant | $2.50 | +22.8K | 103.6K | +28% | +$57.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | A | A | 22,800 | $2.50 | 103,556 | D | — | — | (F1) Represents Restricted Stock Units that vest in four equal quarterly installments beginning on March 15, 2024. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control. (F2) The Restricted Stock Units were issued to the Reporting Person, who elected to take Restricted Stock Units in lieu of $57,000 in cash compensation for services as a board member. |